+44 (0) 1223 755950
+1 832 327 7413
Ankyrin Repeat Domain 1 (ANKRD1) Antibody
REQUEST MORE INFO
Catalogue No: abx004731
Price:
US$217.50
(Size: 20 µl)
Orders to United States ship from United States
Reviews: 
(0 Publications and Reviews)
(0 Publications and Reviews)
Click on the image to see the image legend
ANKRD1 Antibody is a Rabbit Polyclonal antibody against ANKRD1. The protein encoded by this gene is localized to the nucleus of endothelial cells and is induced by IL-1 and TNF-alpha stimulation. Studies in rat cardiomyocytes suggest that this gene functions as a transcription factor. Interactions between this protein and the sarcomeric proteins myopalladin and titin suggest that it may also be involved in the myofibrillar stretch-sensor system.
Research Articles on Ankyrin Repeat Domain 1 (ANKRD1)
| Target | Ankyrin Repeat Domain 1 (ANKRD1) |
| Clonality | Polyclonal |
| Reactivity | Human, Mouse, Rat |
| Tested Applications | ELISA, WB |
| Host | Rabbit |
| Recommended dilutions | ELISA: 1 µg/ml, WB: 1/500 - 1/2000. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-130 of human ANKRD1. |
| Isotype | IgG |
| Form | Liquid |
| Purification | Purified by affinity chromatography. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| UniProt Primary AC | Q15327 (UniProt, ExPASy) |
| UniProt Secondary AC | Q96LE7 |
| UniProt Entry Name | ANKR1_HUMAN |
| Gene Symbol | ANKRD1 |
| GeneID | 27063 |
| NCBI Accession | NP_055206.2 |
| KEGG | hsa:27063 |
| String | 9606.ENSP00000360762 |
| Molecular Weight | Calculated MW: 36 kDa Observed MW: 36 kDa |
| Buffer | PBS, pH 7.3, containing 0.09% sodium azide, 50% glycerol. |
| Concentration | > 0.2 mg/ml |
| Availability | Shipped within 5-10 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |